Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer

Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis

(2012) S. Giacchetti et al.   ANNALS OF ONCOLOGY

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer

(2012) Pasquale F. Innominato et al.   INTERNATIONAL JOURNAL OF CANCER

Translational approaches to treatment-induced symptoms in cancer patients

(2012) Robert Dantzer et al.   Nature Reviews Clinical Oncology

Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin–5-Fluorouracil–Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963)

(2011) Pasquale F. Innominato et al.   CHRONOBIOLOGY INTERNATIONAL

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

(2011) B. I. Rini et al.   JNCI-Journal of the National Cancer Institute

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Chronotherapy and the molecular clock: Clinical implications in oncology☆

(2010) Pasquale F. Innominato et al.   ADVANCED DRUG DELIVERY REVIEWS

Circadian Timing in Cancer Treatments

(2010) Francis Lévi et al.   Annual Review of Pharmacology and Toxicology

The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks

(2010) Charna Dibner et al.   Annual Review of Physiology

Exploratory Analysis of Early Toxicity of Sunitinib in Advanced Hepatocellular Carcinoma Patients: Kinetics and Potential Biomarker Value

(2010) A. X. Zhu et al.   CLINICAL CANCER RESEARCH

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

(2010) Ulrich Gatzemeier et al.   LANCET ONCOLOGY

Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer

(2009) P. F. Innominato et al.   CANCER RESEARCH

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX

(2009) Kohei Shitara et al.   EUROPEAN JOURNAL OF CANCER

Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic Approaches

(2009) Pasquale F. Innominato et al.   INTEGRATIVE CANCER THERAPIES

Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer

(2009) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

(2009) Chantal Quinten et al.   LANCET ONCOLOGY

Methodological Challenges When Using Actigraphy in Research

(2008) Ann M. Berger et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial

(2008) Jack Cuzick et al.   LANCET ONCOLOGY

Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

(2007) Giuseppe Aprile et al.   CANCER